Association between smoking and concomitant diseases in obstructive sleep apnoea (OSA)

Robert Plywaczewski (Warsaw, Poland), Robert Plywaczewski, Anna Czyzak-Gradkowska, Przemyslaw Bielen, Pawel Sliwinski

Source: International Congress 2015 – To treat or not to treat? Sleep-disordered breathing II
Session: To treat or not to treat? Sleep-disordered breathing II
Session type: Thematic Poster Session
Number: 2411
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Robert Plywaczewski (Warsaw, Poland), Robert Plywaczewski, Anna Czyzak-Gradkowska, Przemyslaw Bielen, Pawel Sliwinski. Association between smoking and concomitant diseases in obstructive sleep apnoea (OSA). Eur Respir J 2015; 46: Suppl. 59, 2411

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Influence of smoking on sleep and disease severity in a population of obstructive sleep apnea patients
Source: Annual Congress 2013 –Tobacco use in different countries: crisis to disease
Year: 2013


Genetic determinants of cardiovascular disease in patients with obstructive sleep apnea (OSA)
Source: International Congress 2015 – Ring of fire: inflammation and metabolism in sleep-disordered breathing
Year: 2015


Albuminuria in moderate and severe obstructive sleep apnoea (OSA) patients
Source: International Congress 2015 – Inflammation, biomarkers and hypoxia in sleep disordered breathing
Year: 2015

Prevalence of arterial hypertension in obstructive sleep apnoea (OSA) patients – Impact of diabetes and obesity
Source: Annual Congress 2013 –A metabolic medley: sleep disordered breathing
Year: 2013


The effects of obstructive sleep apnea on cardiovascular functioning in children with obesity
Source: Annual Congress 2013 –Assessing sleep disordered breathing and lung function in children
Year: 2013

Gender differences in comorbidity burden in recently diagnosed obstructive sleep apnea patients
Source: International Congress 2014 – Sleep disordered breathing 1
Year: 2014

Effects of age on severity of disease in an obstructive sleep apnea population
Source: Annual Congress 2013 –Sleep disordered breathing in special situations II
Year: 2013


Use of clinical predictors on diagnosis of OSAS in patients with chronic obstructive pulmonary disease, asthma and cardiovascular diseases
Source: International Congress 2014 – Sleep disordered breathing 3
Year: 2014


Asthma, obesity, metabolic dysfunction and obstructive sleep apnoea
Source: International Congress 2019 – State of the art session: Sleep and breathing disorders
Year: 2019


Transition from obstructive sleep apnea (OSA) to obesity hypoventilation syndrome (OHS)
Source: International Congress 2015 – Measuring sleep-disordered breathing in children and adults I: questionnaires, epidemiology and sleep studies
Year: 2015


Prevalence of metabolic syndrome with obstructive sleep apnea in a Korean population
Source: Annual Congress 2013 –Sleep disordered breathing in special situations III
Year: 2013


Comorbidity burden in obstructive sleep apnea varies by age in men
Source: International Congress 2016 – Effect of sleep apnoea on life-span and comorbidities
Year: 2016


Tobacco smoking and the severity of obstructive sleep apnea syndrome (OSAS)
Source: Annual Congress 2005 - What should we know about our SAS patients
Year: 2005


Evaluation of lipid profile in patients with obstructive sleep apnea syndrome
Source: International Congress 2015 – To treat or not to treat? Sleep-disordered breathing II
Year: 2015


History of preeclampsia and pregnancy induced hypertension among women later diagnosed with obstructive sleep apnea
Source: Annual Congress 2013 –Sleep disordered breathing in special situations II
Year: 2013

Obstructive sleep apnea syndrome (OSA) and hypercoagulability – What is the impact of sole OSA in the absence of comorbities?
Source: Annual Congress 2013 –Sleep disordered breathing in special situations I
Year: 2013

Association between obstructive sleep apnoea (OSA) severity and metabolic disturbances
Source: International Congress 2017 – Obstructive and central sleep apnoea: consequences and comorbidities
Year: 2017

Hypertension among obstructive sleep apnea patients compared to controls. Two year change after starting treatment with CPAP
Source: Annual Congress 2013 –The heart of the matter: sleep disordered breathing
Year: 2013

Prevalence of hyperuricemia in patients with obstructive sleep apnea from the Mallorca cohort
Source: International Congress 2014 – The story continues: impact of OSA on cardiometabolic parameters
Year: 2014


Progression of subclinical atherosclerosis in obstructive sleep apnoea (OSA)
Source: International Congress 2016 – Effects of hypoxia and sleep apnoea on the lung, heart, and vessels
Year: 2016